Percutaneous absorption of betamethasone-17-benzoate.
D000328:Adult; D001565:Benzoates / Q000009:adverse effects / Q000378:metabolism*; D001623:Betamethasone / Q000009:adverse effects / Q000378:metabolism*; D003872:Dermatitis / Q000188:drug therapy; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D010912:Pituitary-Adrenal Function Tests; D011565:Psoriasis / Q000188:drug therapy; D012867:Skin / Q000378:metabolism*
D001565:Benzoates; D001623:Betamethasone; D006854:Hydrocortisone